RECK and hepatocellular carcinoma: For example, MiR-21 could promote the proliferation and metastasis of HCC cells by inhibiting the expression of PTEN, PDCD4, RECK and HSULF-1 (human sulfatase-1), even making HCC cells resistant to chemotherapy.